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Summary-A new optical homogeneous biochemical method for the assay of glucose has been developed, 
based on fluorescence energy transfer between a glucose analog, dextran labeled with fluorescein 
isothiocyanate (FITCdextran), and a glucose-receptor protein, Rhodamine-labeled Concanavalin A 
(RhConA). When FITCdextran binds to RlConA in solution, and is light-activated, the FITC label 
transfers its absorbed energy to the Rhodamine label, which then emits light according to its own 
characteristic fluorescence spectrum. When glucose is added to this solution, the FITC fluorescence 
intensity increases as FITCdextran is released from the RhConA and is replaced by glucose. Thus it 
is possible to determine glucose concentrations directly from the level of FITC fluorescence. 
One of the key elements in the diagnosis and manage- 
ment of disease is the measurement of (a) specific 
endogenous substances which either control homeo- 
static mechanisms or reflect the malfunction of these 
mechanisms and (b) the blood concentrations of 
drugs used to remedy the disorders. Most clinical 
analytical methods are based on techniques which 
require blood samples to be withdrawn from the 
patient and taken to laboratories for analysis, and 
consequently only periodic information is available. 
Because of the skills needed for their performance, 
most such analyses cannot be done outside the labo- 
ratory, e.g., in the home or workplace. 
There are a number of reasons for an intense 
interest in developing simple, accurate, and rapid 
clinical assays which can be used by non-analytical 
chemists, e.g., physicians, nurses, patients. In the 
intensive care setting, where there is a high level of 
expertise, there is a need for continuous monitoring 
of blood for metabolites (e.g., glucose) and relatively 
toxic drugs (e.g., methotrexate, gentamicin). There is 
also an increasing need for patient self-monitoring, 
such as blood glucose by diabetics, and at the inter- 
mediate level, clinical analysis to be performed in the 
doctor’s office to help in rapid diagnosis. 
Until very recently, most approaches for miniature 
continuous biosensors have been based on electro- 
chemical detectors. These can be broadly classified as 
potentiometric or amperometric devices.‘.2 The usual 
electrochemical biosensor consists of a “biochemical” 
layer containing enzymes, organelles, or cells which 
are held in place in front of an electrode by a dialysis 
membrane. The literature is extensive, the groups of 
Rechnitz) and Suzuki4 being particularly prolific. 
*To whom correspondence should be addressed. 
Recently, increasing attention is being given to minia- 
turization of these electrochemical sensors by use of 
thin-film integrated circuit technology.5-7 
There are several problems with electrochemical 
sensors that have not yet been overcome, however. 
1. For potentiometric detectors there is usually 
persistent drift of the working-cell potential with 
time, resulting in a need for frequent standardization 
with solutions of known analyte concentration. 
2. The effect of consumption of analyte in the 
measurement is aggravated for amperometric devices 
because of the limitations in diffusional transport 
between the transducer compartment and the de- 
tector element. 
Thus, enzyme electrodes have had only a “minor 
impact on medical measurement”,8 because the use of 
electrochemical biosensors has mainly been in off-line 
systems where samples can be alternated with 
standards. 
A primary focus of our research on biosensors has 
been to utilize an optical analytical method that will 
be an alternative to the electrochemical biosensor for 
on-line concentration measurements. There are some 
inherent advantages to use of spectrophotometry, 
fluorimetry and light-scattering for analytical pur- 
poses, because of the higher information content of 
the optical domain compared to electrochemical phe- 
nomena. Thus spectral features such as absorption 
or fluorescence at selective frequencies, provide 
additional degrees of freedom to characterize and 
quantify a given analyte in a mixture with other 
substances. 
By use of optical-fiber waveguides, spectro- 
photometric methods can be miniaturized to monitor 
very small samples, since the active portion of the 
sensor is about 1 ~1 in volume. This capability has 
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Fig. I. Schematic of heterogeneous affinity sensor transducer element. 
become especially significant in recent years owing to 
the ready availability of a variety of optical fibers and 
optoelectronic devices for light-sources and de- 
tectors.’ Optical fibers have been used to fabricate 
micro-calorimeters and micro-fluorimeters,” but it is 
only recently that optical-fiber detector elements have 
been coupled to biochemical reactions for the pur- 
pose of developing miniaturized biosensors.” 
The required selectivity was conferred on the bio- 
sensor by using a selective bioreceptor (Concanavalin 
A) and competitive binding between an analog- 
analyte (FITC-dextran) and the analyte (glucose).‘2 
A schematic diagram of the optical biosensor is 
shown in Fig. 1, along with typical dimensions of the 
active transducer element. In this sensor, the receptor 
is immobilized on the inner wall of the hollow dialysis 
fiber. Some typical calibration curves with different 
analytes are shown in Fig. 2. The response of the 
sensor displays the expected pattern for a competitive 
assay, namely a more or less linear response at low 
concentration and a leveling off at higher concen- 
trations as the competing analyte is displaced from 
receptor sites. In addition, the different curves dem- 
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Fig. 2. Effect of binding constant on sensor response. 
the equilibrium binding constant between analyte and 
receptor; the higher the binding constant, the greater 
the sensitivity. 
A major concern in the performance of any sensor 
is its rate of response to changes in concentration. 
There are three physical/chemical processes that con- 
tribute to the dynamic behavior of this sensor: (a) 
diffusion of the analyte through the wall of the 
hollow fiber, (b) the competitive displacement reac- 
tion between analyte, competing analyte and receptor 
sites, and (c) diffusion of the various species within 
the hollow-fiber compartment. The time constants for 
90% completion of these individual steps have been 
estimated or measuredI and found to be about 5 min 
for glucose diffusion through the wall of the dialysis 
fiber, about 1 set for the displacement reaction (at the 
concentration conditions within the lumen), and 
about 3 min for the diffusion of components within 
the lumen. The overall time constant for various 
fabricated sensors ranged from 6 to 12 min. The 
analyses indicated that faster response could be 
achieved by making the sensors with hollow fibers 
with a smaller lumen diameter and/or thinner walls. 
The Schultz and Mansouri sensor gave very good 
short-term stability during in uivo glucose monitoring 
in a heparinized dog, and good long-term stability 
during in oitro experiments. However, further testing 
of the sensor raised several pertinent questions about 
long-term in vitro stability. In our most recent work, 
we have been trying to improve on the design. 
One major simplification of the sensor is to elimi- 
nate the need for chemical immobilization of the 
bioreceptor (ConA) on the hollow fiber wall to 
achieve spatial separation of the free and bound 
forms of FITC-dextran. The chemical immo- 
bilization has often been difficult to reproduce and 
the alignment of the optical and dialysis fibers 
must also be carefully maintained. If the chemical 
immobilization step could be eliminated, physical 
degradation of the dialysis fiber would no longer be 
a factor. Also, the Schultz and Mansouri sensor is not 
capable of automatic on-line recalibration to correct 
for drift of the optical and electrical components. 
Any shift in the calibration must be corrected by 
Fluorescence energy transfer 
using a series of standard glucose solutions. We 
believe that a new optical homogeneous assay which 
we have recently developed for glucose may he used 
in the design of an improved sensor. 
The new assay has all the reaction species in one 
phase and is based on a fluorescence energy transfer 
technique. Most such methods have been developed 
for haptens bearing a chromophore that can quench 
the intrinsic ultraviolet fluorescence of antibody tryp- 
tophan residues’S’5 as the hapten and antibody bind 
together. However, the technique has received rela- 
tively little attention for fluorophores that absorb in 
the visible region. i6~i7 Our approach employs two 
labels that absorb and fluoresce in the visible region, 
FITC-dextran as a donor (fluorescer) and 
Rhodamine-labeled ConA (Rh-ConA) as the ac- 
ceptor (quencher). The competing reactions for the 
system are given in equations (1) and (2). 
Glucose + Rh-ConA 
(Analyte) (Receptor) * (Analyte: Receptor) 
Glucose: Rh-ConA (1) 
FITC-dextran + Rh-ConA 
(Competing Analyte) (Receptor) 
FITC-dextran : Rh-ConA 
=(Competing Analyte : Receptor) (2) 
The efficiency of the energy transfer process is 
directly related to the overlap of the emission spec- 
trum of the donor with the absorption spectrum of 
the acceptor. The hatched region in Fig. 3 shows that 
there is relatively good spectral overlap of the 
fluorescein emission spectrum, maximum at 520 nm, 





Fig. 3. Overlap of FITC emission spectrum with Rhodamine 
absorption spectrum. 
at 550 nm. Increasing the overlap of the spectra 
should increase the efficiency of resonance energy 
transfer between the chromophore pair. When 
FITC-dextran reversibly binds to Rh-ConA, the two 
chromophores are close enough together (<SO A) 
for a significant portion of the fluorescein signal to 
be quenched by the Rhodamine. As glucose is added 
to the system, FITC-dextran is liberated from the 
Rl-ConA, causing the fluorescein signal to increase. 
With this system, it is possible to measure a wide 
range of glucose concentrations by adjusting the 
concentrations of each component to give the highest 
sensitivity over the desired glucose range. An added 
feature of the system is that the Rhodamine 
fluorescence signal is not significantly affected by the 
energy transfer, so it can be used as the internal 
reference for calibration purposes. Because the assay 
is homogeneous, it is possible to eliminate all immo- 
bilization steps and to scale down the assay from the 




Fig. 4. Schematic of affinity sensor transducer element modified for homogeneous assay. 
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4 shows how the sensor would be constructed. Light 
at two different wavelengths, 490 and 550 nm, would 
be alternately passed into the fiber, and the resulting 
signal recorded. A change in the Rhodamine signal 
would indicate a drift in the light-source or detector, 
and a change in the FITC signal would indicate a 
change in the glucose concentration. This flexibility 
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utilizing a selection of commercially available anti- 
bodies, F,, fragments, binding proteins, etc. Fig. 6. Normalized quenching effect of Rh-ConA on FITC 
fluorescence. 
EXPERIMENTAL 
All fluorescence measurements were made with a specially 
designed spectrofluorimeter operated in the ratio mode. For 
measuring fluorescein quenching during energy transfer 
experiments, the excitation and emission wavelengths were 
470 and 520 nm, respectively. All experiments were per- 
formed at 25” in O.OSM phosphate buffer (containing 0.15M 
sodium chloride) at pH 7.4. For the quenching curves, a 
sample containing the desired FITC-dextran concentration 
was added to a cuvette in the spectrofluorimeter. The 
fluorescence intensity of the fluorescein was recorded at a 
single wavelength, 520 nm, after each Rh-ConA addition. 
Additions were made without removing the cuvette from the 
holder, and corrections were made for dilution and the inner 
filter effect from Rhodamine. Glucose titrations were per- 
formed similarly, except that the initial solutions contained 
both FITC-dextran and Rh-ConA at the desired levels. 
There was approximately a 5-min delay between each 
addition of glucose of Rh-ConA to ensure that the binding 
reaction had reached equilibrium. 
PITC-labeled dextran, MW 7.0 x 104, was obtained from 
Pharmacia (Piscataway, NJ), and Rh-ConA from Sigma 
(St. Louis, MO), U.S. Biochemicals (Cleveland, OH) and 
Polysciences (Warrington, PA). 
RESULTS 
Energy transfer between fluorescein and Rho- 
damine was demonstrated by stepwise addition of a 
pH-7.4 buffered solution of Rh-ConA to a solution 
of the FITC-dextran. Figure 5 shows that the 
fluorescein signal significantly decreased as the 
Rh-ConA concentration was increased. As much as 
45% of the fluorescence was quenched at an 
Rh-ConA concentration of 0.33 mg/ml. The data are 
replotted (Fig. 6) in terms of the Rh-ConA/ 
FITC-dextran ratio after correction for non-specific 
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absorption of FITC fluorescence, i.e., the inner filter 
effect. It is easy to see from the figure that the 
relatively weak binding between ConA and dextran 
makes it important to have a large excess of 
Rh-ConA in relation to FITC-dextran in order 
to achieve a significant amount of fluorescence 
quenching. 
When glucose was titrated (reverse titration) by 
addition to a solution of Rh-ConA and FITC- 
dextran, there was the expected increase in 
fluorescence as the glucose displaced FITC-dextran 
from the ConA binding sites. Figure 7 shows the 
fraction of the theoretical maximum fluorescein sig- 
nal recovered during glucose addition to two sol- 
utions with different Rh-ConA/FITC-dextran ratios. 
The theoretical maximum fluorescein signal was de- 
duced from Fig. 6 for each Rh-ConA/FITC-dextran 
ratio by assuming that all the quenched signal would 
be restored when a large excess of glucose was 
added to the sample. For a weight ratio of 217 
for Rh-ConA/FITC-dextran, the fluorescence ap- 
proached the theoretical maximum more rapidly than 
when the ratio was 870. At a glucose concentration 
of 3.00 mg/ml, 60% of the signal was recovered with 
the 217-ratio system, whereas only _ 50% was recov- 
ered with the 870-ratio system. As expected from the 
law of mass action, to achieve the largest signal 
response within a given glucose range, lower 
Rh-ConA/FITC-dextran ratios should be used for 
low glucose concentrations and higher ratios for 
larger glucose concentrations. Although the relative 
signal change at low ratios is large for small changes 
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Fig. 7. Recovery of FITC fluorescence during glucose 
titration: -A-- Rh-ConA/FITC-dextran = 217 w/w; 
Fig. 5. Quenching effect of Rh-ConA on FITC fluorescence. -A-- Rh-ConA/FITC-dextran = 870 w/w. 
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in glucose concentration, the absolute change is 
smaller. Therefore, both the detector sensitivity and 
the level of background fluorescence must be consid- 
ered when specifying the Rh-ConA/FITC-dextran 
ratio. 
DISCUSSION 
The new optical homogeneous assay currently has 
a working range up to 2.00 mg/ml (Fig. 7). The linear 
region of the glucose titration curve can be arranged 
to cover a particular concentration range by adjust- 
ing the Rh-ConA/FITC-dextran ratio. For a larger 
ratio, the titration curve will be linear to higher levels 
of glucose, but the sensitivity to small concentration 
changes will be diminished. There are several other 
ways of adjusting the sensitivity besides changing the 
reactant ratios. If the binding constant is increased, 
then better sensitivities are possible. The sensitivity 
can also be improved by adjusting the exciter/ 
quencher ratio, or by changing the fluorochrome pair 
so that the spectral overlap is larger, without ad- 
versely affecting the absorptivity. Finally, the size of 
the ligand analog can be decreased so that the 
fluorochromes are closer together on binding, which 
would permit more efficient energy transfer. 
There is a practical lower limit to the assay, 
however. For measuring low glucose concentrations, 
the FITC-dextran concentration must also be low, 
making the fluorescein signal smaller and more prone 
to noise effects. Therefore, the FITC-dextran concen- 
tration must be large enough to ensure a good 
signal-to-noise ratio. We have typically used 
FITC-dextran concentrations of 0.5-5.0 pg/ml with 
very good results. 
An upper limit to the dynamic range of the homo- 
geneous glucose biosensor is set by the solubility of 
Rh-ConA. Because the sensor would initially be 
calibrated with all the components in solution, it 
is essential that the components are stable for 
the duration of the experiment. This means that the 
solution must not form insoluble aggregates, or the 
calibration would be changed. For the Rh-ConA/ 
FITC-dextran system, this is particularly critical be- 
cause over a period of hours at 25” ConA will become 
irreversibly aggregated and form precipitates. This 
process is even more rapid at 37”. We have performed 
several experiments to determine whether the stability 
of Rh-ConA could be increased by physical means 
such as changes in temperature, ionic strength, pH, or 
addition of synthetic polymers, but none of these 
methods was able to significantly increase the sta- 
bility of ConA. We are currently trying several 
chemical modification methods, some of which have 
extended the stability of ConA to as long as two 
weeks at 37” without adversely affecting the glucose 
binding. It is expected that there will be an optimum 
set of conditions for the modification procedure since 
there is a limited number of reaction sites on native 
ConA. The greater the number of reaction sites used 
during the chemical modification step, the fewer the 
number of remaining reaction sites available for 
Rhodamine labeling. We will be reporting on this 
work in a subsequent paper. 
CONCLUSIONS 
Our approach to the construction of fiber-optic 
biosensors based on competitive reactions for a bio- 
receptor between an analyte and a fluorescent analog- 
analyte has been extended by the use of homogeneous 
fluorescence quenching techniques. The approach 
described has several advantages over the hetero- 
geneous systems previously reported. 
1. It allows simultaneous monitoring of glucose 
concentrations from the FITC signal and continuous 
internal calibration from the Rhodamine signal to 
correct for light-source and detector sensitivity 
fluctuations. 
2. The receptor does not have to be immobilized on 
the interior wall of the dialysis fiber, so the alignment 
between the optical and dialysis fibers is less critical. 
3. Physical degradation of the dialysis fiber caused 
by the immobilization procedure is no longer im- 
portant. 
4. The assay can be easily scaled down from bench 
experiments to the sensor probe configuration be- 
cause all the reaction components are in a single 
homogeneous solution. 
5. The technique is general in nature, and any 
suitable Rhodamine-labeled bioreceptor, e.g., an 
antibody, F,,a fragment, binding protein, can be 
added directly to the hollow fiber lumen along with 
the macromolecular ligand analog. This makes the 
sensor much more versatile for measuring hormones, 
metabolites *and drugs, since there is no immo- 
bilization chemistry to be developed for each assay 
system. 
On the other hand, in order to achieve the most 
efficient quenching, the overlap of the spectra for the 
two fluorophores needs to be optimized along with 
the relative concentrations of the two fluorophores. A 
higher quenching efficiency will increase the detection 
limit of the assay by increasing the signal-to-noise 
ratio. There are additional considerations that must 
be taken into account when designing a sensor, with 
regard to the relative concentrations and solubilities 
of the bioreceptor and the analyte-analog in the 
sensor compartment. The binding constant must 
be such that the assay gives a linear response over 
the desired analyte range when the bioreceptor and 
analyte analog are used at maximum solubility. 
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